Tanning before transplant: lancing the Langerhans cell

被引：4

作者：

Emerson, SG

机构：

[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA

[2] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA

来源：

NATURE MEDICINE | 2004年 / 10卷 / 05期

关键词：

D O I：

10.1038/nm0504-451

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Ultraviolet radiation thwarts graft-versus-host disease in mice after hematopoietic stem cell transplantation. The treatment kills host Langerhans cells in the skin, which contribute to this deadly disease (pages 510-517).

引用

页码：451 / 452

页数：2

共 9 条

[1] T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions [J].

D'Sa, S ;

Peggs, K ;

Pizzey, A ;

Verfuerth, S ;

Thuraisundaram, D ;

Watts, M ;

White, H ;

Hale, G ;

Waldmann, H ;

Goldstone, A ;

Mackinnon, S ;

Yong, K .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (02) :309-322

[2] The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation [J].

Marks, DI ;

Lush, R ;

Cavenagh, J ;

Milligan, DW ;

Schey, S ;

Parker, A ;

Clark, FJ ;

Hunt, L ;

Yin, J ;

Fuller, S ;

Vandenberghe, E ;

Marsh, J ;

Littlewood, T ;

Smith, GM ;

Culligan, D ;

Hunter, A ;

Chopra, R ;

Davies, A ;

Towlson, K ;

Williams, CD .

BLOOD, 2002, 100 (09) :3108-3114

[3] Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease [J].

Merad, M ;

Hoffmann, P ;

Ranheim, E ;

Slaymaker, S ;

Manz, MG ;

Lira, SA ;

Charo, I ;

Cook, DN ;

Weissman, IL ;

Strober, S ;

Engleman, EG .

NATURE MEDICINE, 2004, 10 (05) :510-517

[4] Langerhans cells renew in the skin throughout life under steady-state conditions [J].

Miriam Merad ;

Markus G. Manz ;

Holger Karsunky ;

Amy Wagers ;

Wendy Peters ;

Israel Charo ;

Irving L. Weissman ;

Jason G. Cyster ;

Edgar G. Engleman .

Nature Immunology, 2002, 3 (12) :1135-1141

[5] Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation [J].

Ratzinger, G ;

Reagan, JL ;

Heller, G ;

Busam, KJ ;

Young, JW .

BLOOD, 2003, 101 (04) :1422-1429

[6] Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants [J].

Ruggeri, L ;

Capanni, M ;

Urbani, E ;

Perruccio, K ;

Shlomchik, WD ;

Tosti, A ;

Posati, S ;

Rogaia, D ;

Frassoni, F ;

Aversa, F ;

Martelli, MF ;

Velardi, A .

SCIENCE, 2002, 295 (5562) :2097-2100

[7] Prevention of graft versus host disease by inactivation of host antigen-presenting cells [J].

Shlomchik, WD ;

Couzens, MS ;

Tang, CB ;

McNiff, J ;

Robert, ME ;

Liu, JL ;

Shlomchik, MJ ;

Emerson, SG .

SCIENCE, 1999, 285 (5426) :412-415

[8] Acute graft-versus-host disease does not require alloantigen expression on host epithelium [J].

Teshima, T ;

Ordemann, R ;

Reddy, P ;

Gagin, S ;

Liu, C ;

Cooke, KR ;

Ferrara, JLM .

NATURE MEDICINE, 2002, 8 (06) :575-581

[9] APCs in the liver and spleen recruit, activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease [J].

Zhang, Y ;

Shlomchik, WD ;

Joe, G ;

Louboutin, JP ;

Zhu, J ;

Rivera, A ;

Giannola, D ;

Emerson, SG .

JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :7111-7118

← 1 →